MetaCap

Lakewood-Amedex Biotherapeutics (LABT) vs Onconetix (ONCO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Onconetix is the larger company by market cap ($2.4 million vs $2.2 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

LABT-71.18%ONCO+383.92%
+1121%+493%-135%
Oct 7, 20261 yearNov 20, 2026
LABT-68.69%ONCO+366.13%
+1076%+473%-129%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

LABT versus ONCO key metrics
MetricLABTONCO
Share price$0.2449$2.89
Market cap$2.19M$2.37M
1-day change+15.03%-8.54%
P/E ratio (TTM)—0.00
EPS (TTM)$-5.57$4,509.80
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$815.37K
Revenue growth (YoY)—-67.70%
Net income (latest FY)—$-14.03M
Gross margin—77.62%
Operating margin—-2190.03%
Net margin—-1720.98%
52-week high$98.20$1,610.00
52-week low$0.17$2.76
Distance from 52-week high-99.75%-99.82%
Analyst consensusstrong_buy—
Avg. price target upside+4799.96%—
Average volume16.14M412.90K
Shares outstanding8.95M820.61K
Employees52
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Lakewood-Amedex Biotherapeutics

LABT stock →

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees

About Onconetix

ONCO stock →

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.

Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees

LABT vs ONCO FAQ

Which is bigger, Lakewood-Amedex Biotherapeutics or Onconetix?

Onconetix (ONCO) is larger, with a market capitalization of $2.37M compared with $2.19M for Lakewood-Amedex Biotherapeutics (LABT).

Are Lakewood-Amedex Biotherapeutics and Onconetix in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons